BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36303230)

  • 21. Clinical association study on the matrix metalloproteinase expression in the serum of patients with connective tissue disease complicated with interstitial lung disease.
    Chen H; Tang J; Liang J; Huang D; Pan C; Liu S; Du X; Tao L
    Arch Rheumatol; 2023 Sep; 38(3):367-374. PubMed ID: 38046255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
    Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
    Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab in connective tissue disease-associated interstitial lung disease.
    Duarte AC; Cordeiro A; Fernandes BM; Bernardes M; Martins P; Cordeiro I; Santiago T; Seixas MI; Ribeiro AR; Santos MJ
    Clin Rheumatol; 2019 Jul; 38(7):2001-2009. PubMed ID: 31016581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum KL-6 as predictive and prognostic marker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
    El-Beheidy R; Domouky AM; Zidan H; Amer YA
    Reumatismo; 2021 Nov; 73(3):. PubMed ID: 34814656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases.
    Hoffmann T; Oelzner P; Franz M; Teichgräber U; Renz D; Förster M; Böttcher J; Kroegel C; Schulze PC; Wolf G; Pfeil A
    Arthritis Res Ther; 2022 May; 24(1):107. PubMed ID: 35551650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability.
    Topcu A; Mursaloglu HH; Yalcinkaya Y; Karakurt S; Yagiz B; Alaca Z; Demir M; Coskun BN; Dalkilic E; Inanc N
    Clin Rheumatol; 2021 Sep; 40(9):3797-3805. PubMed ID: 33811590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.
    Fischer A; Brown KK; Du Bois RM; Frankel SK; Cosgrove GP; Fernandez-Perez ER; Huie TJ; Krishnamoorthy M; Meehan RT; Olson AL; Solomon JJ; Swigris JJ
    J Rheumatol; 2013 May; 40(5):640-6. PubMed ID: 23457378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab for connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis.
    Wang Y; Li L
    Int J Rheum Dis; 2023 Feb; 26(2):225-235. PubMed ID: 36378118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease.
    Kim K; Lee J; Jo YS
    Ther Adv Respir Dis; 2023; 17():17534666231212301. PubMed ID: 37991015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IL-36 cytokines levels in idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung diseases.
    Zhang Q; Guo L; Song X; Lv C; Tang P; Li Y; Ding Q; Li M
    Clin Chim Acta; 2022 May; 530():8-12. PubMed ID: 35219714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease.
    Wang Y; Xie X; Zheng S; Du G; Chen S; Zhang W; Zhuang J; Lin J; Hu S; Zheng K; Mikish A; Xu Z; Zhang G; Gargani L; Bruni C; Hoffmann-Vold AM; Matucci-Cerinic M; Furst DE
    Front Med (Lausanne); 2022; 9():1066111. PubMed ID: 36590969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements.
    Kuwana M; Bando M; Kawahito Y; Sato S; Suda T; Kondoh Y;
    Expert Rev Respir Med; 2023 Jan; 17(1):71-80. PubMed ID: 36786105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study.
    Xu L; Sgalla G; Wang F; Zhu M; Li L; Li P; Xie Q; Lv X; Yu J; Wang G; Wan H; Richeldi L; Luo F
    BMC Pulm Med; 2023 Mar; 23(1):90. PubMed ID: 36941622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and risk factors of interstitial pneumonia with autoimmune features.
    Vahidy S; Agyeman J; Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ; ; Wong AW; Lok S; Morisset J; Fell CD; Shapera S; Gershon AS; Cox G; Halayko AJ; Sadatsafavi M; Wilcox PG; To T
    Respir Med; 2024 Jan; 221():107500. PubMed ID: 38142756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality.
    Rai M; Parthasarathi A; Beeraka NM; Kaleem Ullah M; Malamardi S; Padukudru S; Siddaiah JB; Uthaiah CA; Vishwanath P; Chaya SK; Ramaswamy S; Upadhyay S; Ganguly K; Mahesh PA
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a systematic evaluation of connective tissue disease on diagnosis approach in patients with interstitial lung diseases.
    Hernandez-Gonzalez F; Prieto-González S; Brito-Zeron P; Cuerpo S; Sanchez M; Ramirez J; Agustí C; Lucena CM; Paradela M; Grafia I; Espinosa G; Sellares J
    Medicine (Baltimore); 2020 Jan; 99(4):e18589. PubMed ID: 31977850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum MUC5AC protein levels are correlated with the development and severity of connective tissue disease-associated pulmonary interstitial lesions.
    Weng L; Liu W; Wang L; Wu Z; Liu D; Lin Y; Song S; Yu C; Chen Y; Chen J; Ge S
    Front Immunol; 2022; 13():987723. PubMed ID: 36189284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Idiopathic Pulmonary Fibrosis and Prediction of Disease Severity via Machine Learning Analysis of Comprehensive Metabolic Panel and Complete Blood Count Data.
    Mueller AN; Miller HA; Taylor MJ; Suliman SA; Frieboes HB
    Lung; 2024 Apr; 202(2):139-150. PubMed ID: 38376581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases.
    Hagaman JT; Panos RJ; McCormack FX; Thakar CV; Wikenheiser-Brokamp KA; Shipley RT; Kinder BW
    Chest; 2011 Feb; 139(2):353-360. PubMed ID: 20688927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.